November 15, 2016

FDA-CTP Final Ruling not so final

FDA is withdrawing the direct final rule because the Agency received significant adverse comment. FDA will consider the comments we received on the direct final rule to be comments on the companion proposed rule published at 81 FR 52371 (August 8, 2016).

Leave a Reply

Your email address will not be published. Required fields are marked *